Performance of the Lumenless 4.1‐Fr Diameter Pacing Lead Implanted at Alternative Pacing Sites in Congenital Heart: A Chronic 5‐Year Comparison

Abstract

The new 4.1-Fr lumenless lead shows similar performance indices to established leads even at APS, yet is thinner and achieves APS with technical ease, permitting more efficient chronic pacing in children and all patients with CHD.